Review tally, page-880

First 880 Last

Share
Profile

Follow
tallplumber

5,002 Posts.

756

28/10/23

14:39

Post #: 70592743
Share

Originally posted by the trickster ↑

I have already said Justin Miller needs to go. In fact I have stated this numerous times.
He is not fit to be a CEO , he simply does not have the capability and skill sets.
Moreover, he cannot sell, he doesnt know how and you see this in his presentations.
There wont be any takeover.
The company is still going not because of him but in spite of him.
What has happened is the usual market pricing on expectations has inverted, it happens when companies disappoint consistently, but reverts back if they start delivering. What has also happened is that he has always tried to spin things rather than being forthright, goes back to his inability to sell, he doesnt get it.
If he were to leave immediately , the stock would rally significantly.
That said, I get the sense things will turn, they have finally got a coherent strategy. Their fundamental problem has not been units sold per point of sale, but points of sale, they simply have never had the critical mass of points of sale to generate real volume. 300 initial Best Buy POS is simply not enough. At best they have never had more than a small number real POS and these OTC products are not really online products. With 5000 POS plus and I believe with another 1000 to 2000 additional POS to be added, this finally gives them the foot print to generate serious revenue.
The positive thing is Walmart as with Best Buy is being invoiced up front in these initial stages and not on consignment so that will be very beneficial from a cashflow perspective.

Expand

Spot on
This could be back to a $250mill MC in the blink of an eye in the next 12mnths if the rollout goes well and we get a couple of left field OEMS
Kudos for having the patients to continually battle with so really strange attitudes on here
Even the holders sound like they are just looking for any reason for this to fail

NUH Price at posting: 13.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

QML

QMines jumps +4.6% on drill hits boasting high copper grades

SKC

SkyCity jumps 2% after copping A$3.6M fine from NZ High Court – far below AUSTRAC's fine

QXR

QX Resources increases US lithium footprint with key agreements

LGM

Legacy hits high-grade gold, silver and copper through drilling at NSW's Bauloora

There are more pages in this discussion • 366 more messages in this thread...

First 880 Last

Add NUH (ASX) to my watchlist

(20min delay)
Last 8.1¢		Change 0.000(0.00%)		Mkt cap ! $21.91M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Review tally, page-880

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

QMines jumps +4.6% on drill hits boasting high copper grades

SkyCity jumps 2% after copping A$3.6M fine from NZ High Court – far below AUSTRAC's fine

QX Resources increases US lithium footprint with key agreements

Legacy hits high-grade gold, silver and copper through drilling at NSW's Bauloora

Featured News

Featured News

Review tally, page-880

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

QMines jumps +4.6% on drill hits boasting high copper grades

SkyCity jumps 2% after copping A$3.6M fine from NZ High Court – far below AUSTRAC's fine

QX Resources increases US lithium footprint with key agreements

Legacy hits high-grade gold, silver and copper through drilling at NSW's Bauloora

Featured News

Featured News